Xueqing Yu
ORCID: 0000-0001-8624-744XAlso affiliated with Guangdong-Hongkong-Macau Joint Laboratory of Collaborative Innovation for Environmental Quality, The First Affiliated Hospital, Sun Yat-sen University, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Southern Medical University
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis”.
Richard Furie, Y K Onno Teng, Gabriel Contreras, Ana Malvar, Xueqing Yu +8 more
Juncheng Zhuang, Li Fan, Xia Zou, Kei Hang Katie Chan, Xueqing Yu +2 more
Lingling Zheng, Kei Hang Katie Chan, Xia Zou, Jihui Zhang, Jundong Liu +7 more